Q1 2024 Holdings
Filed 2024-05-15 | 57 holdings | $834.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $165.0M | 2,806,980 | 19.8% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $49.2M | 1,241,300 | 5.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $41.4M | 1,380,667 | 5.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $38.1M | 2,369,000 | 4.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $35.3M | 1,242,945 | 4.2% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $34.7M | 1,943,836 | 4.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $30.9M | 1,140,000 | 3.7% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $23.3M | 2,060,100 | 2.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $22.6M | 1,093,503 | 2.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $22.1M | 2,425,000 | 2.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $21.7M | 506,604 | 2.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $21.3M | 690,000 | 2.6% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $20.2M | 2,153,000 | 2.4% |
| Perspective Therapeutics Inc | COM | 46489V104 | $17.5M | 14,718,422 | 2.1% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $15.9M | 405,000 | 1.9% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $15.9M | 260,000 | 1.9% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $14.9M | 2,854,000 | 1.8% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $14.7M | 500,811 | 1.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $14.7M | 2,050,000 | 1.8% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.6M | 194,000 | 1.6% |
| Aerovate Therapeutics Inc | COM | 008064107 | $11.9M | 403,685 | 1.4% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $11.8M | 200,000 | 1.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $10.9M | 620,000 | 1.3% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $10.8M | 9,187,883 | 1.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $9.6M | 408,000 | 1.2% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $9.0M | 3,000,000 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.8M | 273,289 | 1.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $8.7M | 3,030,000 | 1.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $8.6M | 340,000 | 1.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $8.3M | 1,501,114 | 1.0% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $7.7M | 18,604,650 | 0.9% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $7.2M | 250,000 | 0.9% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $7.1M | 550,000 | 0.9% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $6.8M | 315,000 | 0.8% |
| Pepgen Inc(PEPG) | COM | 713317105 | $5.5M | 376,117 | 0.7% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $5.1M | 1,000,000 | 0.6% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $5.0M | 1,374,870 | 0.6% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $4.8M | 455,000 | 0.6% |
| Mersana Therapeutics Inc | COM | 59045L106 | $4.5M | 1,000,000 | 0.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $4.1M | 625,000 | 0.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $3.8M | 520,800 | 0.5% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $3.7M | 2,250,000 | 0.4% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $3.7M | 165,000 | 0.4% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $3.6M | 360,800 | 0.4% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $3.6M | 1,103,000 | 0.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $3.2M | 720,000 | 0.4% |
| Allovir Inc | COM | 019818103 | $3.2M | 4,200,000 | 0.4% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $2.7M | 3,800,000 | 0.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $2.6M | 292,000 | 0.3% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $2.6M | 240,000 | 0.3% |